ArticleiScience2025

RBC balanced immuno-inflammatory signatures identify advanced breast cancer patients on CDK4/6 inhibitors at increased risk of progression and death.

Jiayi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.